1) SPVC
选择性门静脉化疗
1.
objective: To evaluate the clinical significance of selective portal vein chemotherapy (SPVC) and percutaneous ethanol injection therapy (PEIT) guided by color Doppler ultrasonography (CDU) after transhepatic arterial chemo-embolization (TACE).
目的 :探讨彩超引导下经皮经肝选择性门静脉化疗 ( SPVC)结合瘤内无水酒精注射疗法 ( PEIT)联合肝动脉栓塞化疗 ( TACE)治疗中晚期肝癌的临床应用价值。
3) selective portal vein embolization
选择性门静脉栓塞
1.
Objective To compare the effect of radio frequency ablation (RFA ), transcatheter artery embolization(TAE), selective portal vein embolization(SPVE) and TAE combined with SPVE in the treatment of hepatic VX 2 tumors.
目的 比较射频消融 (RFA)、肝动脉栓塞化疗 (TAE)、选择性门静脉栓塞 (SPVE)及TAE联合SPVE治疗兔肝VX2 肿瘤的疗效。
4) Preoperative portal vein embolization
术前选择性门静脉栓塞
5) portal vein chemotherapy
门静脉化疗
1.
Influence of hepatectomy combined with hepaticer artery ligation and portal vein chemotherapy for hepatocellular carcinoma on the expression of MDR-1 and MRP and significance;
肝癌切除术并肝动脉结扎和门静脉化疗对复发肝癌表达MDR1和MRP的影响及意义
2.
Portal vein chemotherapy in early stage in preventing postoperative cancer of the large intestine from transfering cancer of the liver;
手术后早期门静脉化疗预防大肠癌肝转移
3.
Clinical study of treatment of primary hepatic carcinoma by hepatectomy combined with portal vein chemotherapy;
门静脉化疗配合肝切除治疗原发性肝癌临床研究
6) Selective intra-arterial chemotherapy
选择性动脉内化疗
1.
Conclusion: Selective intra-arterial chemotherapy has more advantages of simple application,short time consuming,slight wound and repeated t.
目的:总结选择性动脉内化疗治疗颅内恶性肿瘤的护理经验。
补充资料：门静脉插管化疗栓塞术
门静脉插管化疗栓塞术
the chemo?embolization of portal vein
由门静脉属支插管至或近门静脉的肿瘤分支，经该导管进行化学栓塞治疗的方法。门静脉参与肝癌血供及门静脉癌栓是肝癌肝内转移、复发及影响其预后的重要因素。故通过脐静脉、胃网膜静脉、回结肠静脉或经皮肝门静脉穿刺插管等方式，将导管送至或近其肿瘤分支处，如用带球囊导管则先膨胀球囊以防止栓塞剂反流，经导管注入抗癌药及栓塞剂；常用抗癌药有阿霉素、丝裂霉素、氟尿嘧啶、顺铂等；栓塞剂如碘油、明胶海绵粒、自凝血块、纤维蛋白等。该法常与肝动脉栓塞术合并使用，疗效较单一栓塞术好。肿瘤及门静脉癌栓的坏死率更高，但相应的肝组织损伤较大，须掌握好其适应证。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条